AASLD ✓

@AASLDtweets · Alexandria, VA · joined 12 Aug 2009

AASLD is the leading organization of scientists and health care professionals committed to preventing and curing liver disease. @AASLDFoundation @AASLDPresident

33 795Followers

4 066Following

26 294Posts total

7.2KViews on collected posts

Against accounts of the same size

7 posts from the last 90 days, next to the 10K–100K follower range. ordinary reach for its size, weaker reaction than most.

Median views1 164this account949median for 10K–100K

Reach, %3.44%this account3.23%median for 10K–100K

Engagement, %0.82%this account2.00%median for 10K–100K

Metric	This account	Median for 10K–100K	Ratio
Median views per post	1 164	949	1.23×
Reach (views ÷ followers)	3.44%	3.23%	1.07×
Engagement rate	0.82%	2.00%	0.41×

Others in this range → Compare with another account → How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

1.2K31 Aug

1.3K2 Sep

2.3K3 Sep

1.1K

1.2K4 Sep

Last 7 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.26%31 Aug

1.19%2 Sep

0.00%

0.92%3 Sep

0.44%

7.14%

0.82%4 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 2.00%.

What the audience does

Likes68.4%39 in total

Reposts19.3%11 in total

Replies5.3%3 in total

Quotes5.3%3 in total

Bookmarks1.8%1 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

On Sept. 10, join AASLD along with @IDSAInfo, @ESCMID, and @INHepSU, as they discuss their collective progress toward HCV elimination. Register today to learn about populations who are at increased risk for HCV, approaches to strengthen elimination efforts through 2030, and more. 1.2K views · 6 likes · 3 reposts · 1 replies 04 Sep 2026 · Open on X →

@AASLDtweets Well deserved honor!! 👏 14 views · 1 likes · 0 reposts · 0 replies 03 Sep 2026 · Open on X →

Are you ready to explore a future in academic medicine? Join AASLD and AGA on March 5-7, 2027, in Chicago, for this three-day program that bring experts and mentors directly to you. Learn how at: https://t.co/wtquHZTZcN https://t.co/Mix3FH1aBS 1.1K views · 3 likes · 2 reposts · 0 replies 03 Sep 2026 · Open on X →

Meet Dr. Alina M. Allen, a leading voice in the future of MASLD/MASH research! Swipe to learn more about her groundbreaking work and see the #TLM26 sessions where you can hear her insights firsthand. 👉 Learn more about Dr. Allen's sessions here: https://t.co/woXCBOmDUJ https:// 2.3K views · 16 likes · 2 reposts · 1 replies 03 Sep 2026 · Open on X →

@AASLDtweets I’m curious how the panel will weigh anticoagulation when transplant candidacy and bleeding risk point in opposite directions. Sci-Quest can help map the literature beforehand: https://t.co/AMUYFvZ8PU 17 views · 0 likes · 0 reposts · 0 replies 02 Sep 2026 · Open on X →

While you're on-the-go, explore the current evidence and controversies of portal vein thrombosis in portal hypertension with this Sept. 8 webinar. Register to learn more on transplant candidacy, severity of liver disease, extent of thrombosis, and bleeding risk. Register now: ht 1.3K views · 11 likes · 3 reposts · 1 replies 02 Sep 2026 · Open on X →

Looking for quick learning sessions? Take your #viralhepatitis education on-the-go! AASLD endorses two @Medscape Education activities exploring how to identify opportunities for hepatitis screening, integrate vaccination into routine care, and use patient-centered communication 1.2K views · 2 likes · 1 reposts · 0 replies 31 Aug 2026 · Open on X →